By Chris Seper
Three Pennsylvania companies — a diagnostics business, an imaging company and another creating a treatment for head lice — were among nine businesses to receive a share of $1.8 million from Ben Franklin Technology Partners of Southeastern Pennsylvania.
Molecular Detection, a Wayne-based company that recently raised $1.4 million, received $250,000. The company is raising up to $2.5 million to further develop its Detect-Ready technology, which tests nasal samples for MRSA, an antibiotic-resistant staph infection. BFTP previously invested a $500,000 in the company.
Real Time Tomography of Villanova received $275,000. The company builds two-dimensional and three-dimensional imaging systems that can deliver clearer images faster than existing solutions and can also integrate easily into current systems. BFTP previously invested $150,000 in the company.
And Topaz Pharmaceuticals, based in Horsham, received $500,000. The company is developing a topical cream that treats head lice and is in the midst of Phase III clinical trials. The cream is made from ivermectin, which has been used to treat worm infestations as well as river blindness. BFTP previously invested $250,000.
At DeviceTalks Boston, Tyler Shultz will give attendees an inside look at Theranos and how he was able to sound the alarm after he realized the company was falling apart. Shultz will take attendees behind the story that everyone is talking about: the rise and fall of Elizabeth Holmes and her diagnostic company, Theranos.
Join Shultz and 1,000+ medical device professionals at the 8th annual DeviceTalks Boston.